Biotech entity
Every one of those 1 sits in a single category, ipo. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline.
Last mentioned: Mar 17, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, ipo. The 5 average consequence score is below the beat benchmark of 6.3 in the same window. Source depth averages 2 original sources per story, versus 3.3 across the same-window beat baseline. GSP Crop Science appears in 1 tracked Biotech story from March 17, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Expected Closing
Final day for institutional and retail investors to bid for shares.
Day 2 Subscription
Market reports muted response with 0% GMP and steady bidding.
IPO Opening
Subscription opens for the Rs 400 crore public issue.
GSP Crop Science has launched its Rs 400 crore initial public offering with a price band of Rs 304-320, primarily targeting debt reduction. Despite the company's established position in the agrochemical sector, early subscription data and a stagnant grey market premium suggest a cautious reception from investors.
Source: economictimes.indiatimes.com · economictimes.indiatimes.com
GSP Crop Science is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
